We have previously created similar treatment for cancer based upon the NKG2D-ovarian cancer honing molecule [14, 15] or the Annexin A5 molecule [16, 17], which showed the potential clinical applications and the importance of using antigen-specific immunotherapy to reverse immune tolerance. Here, KLRK1 is linked to cancer.